World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
75
Citations
19348
World Ranking
1507
National Ranking
125

Overview

Elizabeth M. Johnson is affiliated with the Government of the United Kingdom and has a research focus spanning multiple fields related to medicine and biology. Their work primarily concentrates on infectious diseases, epidemiology, and molecular biology, intersecting with fungal infections and antifungal resistance studies.

The scientist's main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, Johnson's subfields of study are:

  • Infectious Diseases
  • Epidemiology
  • Cell Biology
  • Molecular Biology
  • Plant Science

The core research topics addressed in Johnson's publications cover:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Plant pathogens and fungal diseases
  • Mycorrhizal fungi and plant interactions
  • Yeasts and rust fungi studies
  • Nail diseases and treatments
  • Infectious diseases and mycology

Recent publications include:

  • Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment, 2022, Nature Microbiology
  • Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis, 2020, European Respiratory Journal
  • Name Changes for Fungi of Medical Importance, 2018 to 2019, 2020, Journal of Clinical Microbiology
  • COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory, 2020, Journal of Clinical Microbiology
  • CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris, 2020, Medical Mycology

Frequent coauthors in Johnson's research include:

  • Andrew M. Borman
  • Mark Fraser
  • Alireza Abdolrasouli
  • Matthew C. Fisher
  • Johanna Rhodes

Johnson's work has been published extensively in journals such as:

  • Journal of Clinical Microbiology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Medical Mycology
  • Journal of Fungi
  • ClinMicroNow

Best Publications

  • Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections

    John R. Perfect;Kieren A. Marr;Thomas J. Walsh;Richard N. Greenberg

  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll

  • Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

    H. Ruth Ashbee;Rosemary Ann Barnes;Elizabeth M. Johnson;Malcolm D. Richardson

  • Candida auris: a Review of the Literature.

    Anna Jeffery-Smith;Surabhi K. Taori;Silke Schelenz;Katie Jeffery

  • ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    A.M. Tortorano;M. Richardson;E. Roilides;A. van Diepeningen

  • A Candida auris Outbreak and Its Control in an Intensive Care Setting.

    David W Eyre;Anna E Sheppard;Hilary Madder;Ian Moir

  • Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris

    Leighann Sherry;Gordon Ramage;Ryan Kean;Andrew Borman

  • A Plasmid-Based Reverse Genetics System for Animal Double-Stranded RNA Viruses

    Takeshi Kobayashi;Annukka A.R. Antar;Karl W. Boehme;Pranav Danthi

  • ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

    A. Chowdhary;J. F. Meis;J. Guarro;G. S. de Hoog

  • Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

    Elizabeth M. Johnson;David W. Warnock;Jane Luker;Stephen R. Porter

  • Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

    M. A. Pfaller;D. J. Diekema;J. H. Rex;A. Espinel-Ingroff

  • Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.

    D W Denning;S A Radford;K L Oakley;L Hall

  • Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.

    Benoît P. Guery;Maiken C. Arendrup;Georg Auzinger;Élie Azoulay

  • Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species

    Andrew M. Borman;Adrien Szekely;Elizabeth M. Johnson

  • In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.

    E M Johnson;A Szekely;D W Warnock

  • The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.

    P. Lewis White;Christopher J. Linton;Michael D. Perry;Elizabeth M. Johnson

  • Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment

    Unknown

  • Management and outcome of bloodstream infections due to Candida species in England and Wales.

    C. C. Kibbler;S. Seaton;Rosemary Ann Barnes;W. R. Gransden

  • Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

    A. Espinel-Ingroff;D. J. Diekema;A. Fothergill;Elizabeth Johnson

  • Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance.

    Ryan Kean;Ryan Kean;Christopher Delaney;Leighann Sherry;Andrew Borman

  • In Vitro Studies of Activity of Voriconazole (UK-109,496), a New Triazole Antifungal Agent, against Emerging and Less-Common Mold Pathogens

    S A Radford;E M Johnson;D W Warnock

  • Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

    A. Espinel-Ingroff;A.I. Aller;E. Canton;L.R. Castanon-Olivares

  • Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades

    Andrew M. Borman;Colin K. Campbell;Mark Fraser;Elizabeth M. Johnson

  • Molecular identification of pathogenic fungi

    Andrew M Borman;Christopher J Linton;Sarah-Jane Miles;Elizabeth M Johnson

Frequent Co-Authors

Andrew M. Borman
Andrew M. Borman Public Health England
David W. Warnock
David W. Warnock Centers for Disease Control and Prevention
Ana Espinel-Ingroff
Ana Espinel-Ingroff Virginia Commonwealth University Medical Center
Malcolm Richardson
Malcolm Richardson University of Manchester
John D. Turnidge
John D. Turnidge University of Adelaide
Maiken Cavling Arendrup
Maiken Cavling Arendrup Statens Serum Institut
Luis Ostrosky-Zeichner
Luis Ostrosky-Zeichner The University of Texas Health Science Center at Houston
Teun Boekhout
Teun Boekhout University of Amsterdam
Jacques F. Meis
Jacques F. Meis Canisius-Wilhelmina Ziekenhuis
Manuel Cuenca-Estrella
Manuel Cuenca-Estrella Instituto de Salud Carlos III

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens the door to various related online degrees and career pathways. Many students explore online medical programs to complement their microbiology background, offering flexibility and accessibility while preparing for healthcare roles.

Public health is another popular path, with several accredited online MPH programs easy to get into available for microbiology graduates. These programs focus on population health, epidemiology, and preventive medicine, expanding career options in health policy and community health.

For those interested in specialized support roles, becoming a child life specialist is a rewarding option. Understanding how much does a child life specialist make and the required qualifications can help microbiology students plan a stable career working with children in medical environments.

Additionally, many institutions offer college degrees for felons, ensuring broader access to education and careers in science and health fields. This inclusivity supports diverse student populations pursuing microbiology-related professions.

Best Scientists Citing Elizabeth M. Johnson

Trending Scientists

Recently Published Articles